37 results
8-K
EX-99.1
d9ln 68hdm
13 Feb 24
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.2
hp8hvpql
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
EX-4.7
bqu11
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.8
4xo1pb5213 249r21n
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.9
seuvv71o5nme3x qgp
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.3
yqru3
13 Feb 24
Automatic shelf registration
4:04pm
8-K
EX-2.1
e68ht1ukplbp1fc
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
S-8
EX-99.4
0gdgoqdgpuvilepe
2 Feb 24
Registration of securities for employees
4:04pm
8-K
EX-10.1
wj2eosooh0 oh38
29 Dec 23
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.2
27j84cjfm1gy yfzak
29 Dec 23
Departure of Directors or Certain Officers
5:00pm
424B3
1po2j6bww1g35v9p
28 Aug 23
Prospectus supplement
9:10am
S-4/A
eixbztod4lo 6rs
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4
sv3jllj0pnn5
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm